Shanghai Junshi (China) Today
| 688180 Stock | 29.97 0.13 0.43% |
Performance8 of 100
| Odds Of DistressLess than 19
|
Shanghai Junshi is trading at 29.97 as of the 18th of December 2024, a 0.43 percent decrease since the beginning of the trading day. The stock's open price was 30.1. Shanghai Junshi has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 29th of December 2022 and ending today, the 18th of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Shanghai Junshi is entity of China. It is traded as Stock on SHG exchange. The company has 765.58 M outstanding shares. More on Shanghai Junshi Biosciences
Moving together with Shanghai Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shanghai Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shanghai Junshi's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shanghai Junshi or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CoCEO Director | Cong Li | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Shanghai Junshi's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shanghai Junshi's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsShanghai Junshi can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shanghai Junshi's financial leverage. It provides some insight into what part of Shanghai Junshi's total assets is financed by creditors.
| |||||
Shanghai Junshi Biosciences (688180) is traded on Shanghai Stock Exchange in China and employs 2,568 people. Shanghai Junshi is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 25.53 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanghai Junshi's market, we take the total number of its shares issued and multiply it by Shanghai Junshi's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanghai Junshi Bios operates under Biotechnology sector and is part of Health Care industry. The entity has 765.58 M outstanding shares.
Shanghai Junshi generates negative cash flow from operations
Check Shanghai Junshi Probability Of Bankruptcy
Ownership AllocationShanghai Junshi Bios shows a total of 765.58 Million outstanding shares. Shanghai Junshi Bios maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shanghai Ownership Details
Shanghai Junshi Bios Risk Profiles
Although Shanghai Junshi's alpha and beta are two of the key measurements used to evaluate Shanghai Junshi's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.61 | |||
| Semi Deviation | 2.51 | |||
| Standard Deviation | 3.83 | |||
| Variance | 14.7 |
Shanghai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai Junshi without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Shanghai Junshi Corporate Directors
Other Information on Investing in Shanghai Stock
Shanghai Junshi financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Junshi security.